Atlas Capital Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.4K | Hold |
5,000
| – | – | 0.01% | 634 |
|
|
2025
Q1 | $36.7K | Hold |
5,000
| – | – | ﹤0.01% | 664 |
|
|
2024
Q4 | $42.7K | Buy |
+5,000
| New | +$42.7K | 0.01% | 635 |
|
|
2024
Q3 | – | Sell |
-5,000
| Closed | -$34.2K | – | 944 |
|
|
2024
Q2 | $34.2K | Buy |
+5,000
| New | +$34.2K | ﹤0.01% | 633 |
|
|
2024
Q1 | – | Sell |
-5,000
| Closed | -$22.3K | – | 945 |
|
|
2023
Q4 | $22.3K | Hold |
5,000
| – | – | ﹤0.01% | 681 |
|
|
2023
Q3 | $15.7K | Hold |
5,000
| – | – | ﹤0.01% | 661 |
|
|
2023
Q2 | $25.8K | Hold |
5,000
| – | – | ﹤0.01% | 648 |
|
|
2023
Q1 | $26.4K | Hold |
5,000
| – | – | ﹤0.01% | 644 |
|
|
2022
Q4 | $14.1K | Hold |
5,000
| – | – | ﹤0.01% | 696 |
|
|
2022
Q3 | $20.8K | Hold |
5,000
| – | – | ﹤0.01% | 650 |
|
|
2022
Q2 | $20.1K | Hold |
5,000
| – | – | ﹤0.01% | 681 |
|
|
2022
Q1 | $24.8K | Hold |
5,000
| – | – | ﹤0.01% | 618 |
|
|
2021
Q4 | $34.9K | Hold |
5,000
| – | – | 0.01% | 574 |
|
|
2021
Q3 | $50K | Hold |
5,000
| – | – | 0.01% | 521 |
|
|
2021
Q2 | $70.9K | Hold |
5,000
| – | – | 0.01% | 494 |
|
|
2021
Q1 | $82.1K | Hold |
5,000
| – | – | 0.02% | 438 |
|
|
2020
Q4 | $104K | Buy |
+5,000
| New | +$104K | 0.02% | 391 |
|
|
2020
Q3 | – | Sell |
-5,000
| Closed | -$41.7K | – | 500 |
|
|
2020
Q2 | $41.7K | Hold |
5,000
| – | – | 0.01% | 498 |
|
|
2020
Q1 | $24.8K | Hold |
5,000
| – | – | 0.01% | 500 |
|
|
2019
Q4 | $19.8K | Hold |
5,000
| – | – | ﹤0.01% | 546 |
|
|
2019
Q3 | $15.2K | Hold |
5,000
| – | – | ﹤0.01% | 543 |
|
|
2019
Q2 | $22K | Hold |
5,000
| – | – | 0.01% | 548 |
|
|
2019
Q1 | $19.9K | Hold |
5,000
| – | – | 0.01% | 486 |
|
|
2018
Q4 | $19.9K | Buy |
+5,000
| New | +$19.9K | 0.01% | 467 |
|